n.a. (ANAC)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Anacor Pharmaceuticals (ANAC) Is Today's Water-Logged And Getting Wetter Stock

Anacor Pharmaceuticals (ANAC) Is Today's Water-Logged And Getting Wetter Stock

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Anacor Pharmaceuticals To Present Data From Long-Term Safety Study Of Crisaborole Topical Ointment, 2% In Patients With Mild-to-Moderate Atopic Dermatitis At Upcoming Medical Conference

Anacor Pharmaceuticals To Present Data From Long-Term Safety Study Of Crisaborole Topical Ointment, 2% In Patients With Mild-to-Moderate Atopic Dermatitis At Upcoming Medical Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that it will present data from the long-term safety study of crisaborole topical ointment, 2% in children and adults with mild-to-moderate atopic dermatitis at the...

Anacor Pharmaceuticals Submits New Drug Application To The FDA For Crisaborole Topical Ointment, 2% For The Treatment Of Mild-to-Moderate Atopic Dermatitis

Anacor Pharmaceuticals Submits New Drug Application To The FDA For Crisaborole Topical Ointment, 2% For The Treatment Of Mild-to-Moderate Atopic Dermatitis

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that it has submitted a New Drug Application (NDA) to the U.

Insider Trading Alert - TEP, CRUS And ANAC Traded By Insiders

Insider Trading Alert - TEP, CRUS And ANAC Traded By Insiders

Stocks with insider trader activity include TEP, CRUS and ANAC

The Nominees for Best Biopharma CEO of 2015 Are...

The Nominees for Best Biopharma CEO of 2015 Are...

One of these biopharma executives, or the grouped nominees, will win the Swanson Trophy, named in honor of Robert Swanson, Genentech's founding CEO. Here are the best biopharma CEOs.

3 Rising Biotechs That Should Continue Their Upward Trends

3 Rising Biotechs That Should Continue Their Upward Trends

Intra-Cellular Therapies, Prothena and Anacor have solid fundamentals and growth prospects for the new year.

Anacor Pharmaceuticals To Present At The Jefferies Autumn 2015 Global Healthcare Conference

Anacor Pharmaceuticals To Present At The Jefferies Autumn 2015 Global Healthcare Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that the company's management team will present at the Jefferies Autumn 2015 Global Healthcare Conference on Wednesday, November 18, 2015 at 8:40 a.

Anacor Pharmaceuticals (ANAC) Showing Signs Of A Dead Cat Bounce Today

Anacor Pharmaceuticals (ANAC) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "dead cat bounce" (down big yesterday but up big today) candidate

Anacor Pharmaceuticals (ANAC) Weak On High Volume

Anacor Pharmaceuticals (ANAC) Weak On High Volume

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a weak on high relative volume candidate

Anacor Pharmaceuticals Reports Third Quarter 2015 Financial Results

Anacor Pharmaceuticals Reports Third Quarter 2015 Financial Results

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced its financial results for the quarter ended September 30, 2015.

Woes At Valeant Distributor Philidor Seen As Boon For Anacor

Woes At Valeant Distributor Philidor Seen As Boon For Anacor

After both CVS Health and Express Scripts confirmed last night that they have removed Philidor, the specialty pharmacy used by Valeant, from their pharmacy-benefit management networks, the embattled drugmaker announced...

Anacor Pharmaceuticals Announces Top-Line Results From Long-Term Safety Study Of Crisaborole Topical Ointment, 2% In Patients With Mild-to-Moderate Atopic Dermatitis

Anacor Pharmaceuticals Announces Top-Line Results From Long-Term Safety Study Of Crisaborole Topical Ointment, 2% In Patients With Mild-to-Moderate Atopic Dermatitis

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced top-line results from the long-term safety study of Crisaborole Topical Ointment, 2% (formerly AN2728), a novel non-steroidal topical anti-inflammatory...

Anacor Pharmaceuticals (ANAC) Showing Signs Of Perilous Reversal Today

Anacor Pharmaceuticals (ANAC) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "perilous reversal" (up big yesterday but down big today) candidate

Anacor Pharmaceuticals To Report Third Quarter 2015 Financial Results On November 3, 2015

Anacor Pharmaceuticals To Report Third Quarter 2015 Financial Results On November 3, 2015

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the quarter ended September 30, 2015, before the market opens on Tuesday, November 3, 2015.

Anacor Pharmaceuticals (ANAC) Flagged As Strong On High Volume

Anacor Pharmaceuticals (ANAC) Flagged As Strong On High Volume

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a strong on high relative volume candidate

Today's Weak On High Volume Stock: Anacor Pharmaceuticals (ANAC)

Today's Weak On High Volume Stock: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a weak on high relative volume candidate

10 Best Nasdaq Biotech Stocks in the Third Quarter

10 Best Nasdaq Biotech Stocks in the Third Quarter

Here are the 10 stocks in the biotech sector which had the best third-quarter.

Anacor Pharmaceuticals Announces Presentations Of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data At Two Upcoming Medical Conferences

Anacor Pharmaceuticals Announces Presentations Of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data At Two Upcoming Medical Conferences

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that data from the Phase 3 pivotal studies of investigational drug Crisaborole Topical Ointment, 2% will be presented at two upcoming medical meetings.

Perilous Reversal Stock: Anacor Pharmaceuticals (ANAC)

Perilous Reversal Stock: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "perilous reversal" (up big yesterday but down big today) candidate

Bull Chart of the Day: Anacor Pharmaceuticals

Shares appear ready to push forward after three months of consolidating.

Anacor Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference

Anacor Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that the company's management team will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015 at 4:15 p.

Barbarian At The Gate: Anacor Pharmaceuticals (ANAC)

Barbarian At The Gate: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Today's Water-Logged And Getting Wetter Stock: Anacor Pharmaceuticals (ANAC)

Today's Water-Logged And Getting Wetter Stock: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Anacor Pharmaceuticals To Present At The 2015 Wedbush PacGrow Healthcare Conference

Anacor Pharmaceuticals To Present At The 2015 Wedbush PacGrow Healthcare Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company's Chairman, President and Chief Executive Officer, will provide a company overview at the Wedbush PacGrow Healthcare Conference on...

Anacor Pharmaceuticals Reports Second Quarter 2015 Financial Results

Anacor Pharmaceuticals Reports Second Quarter 2015 Financial Results

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced its financial results for the quarter ended June 30, 2015.

Anacor Pharmaceuticals To Report Second Quarter 2015 Financial Results On August 6, 2015

Anacor Pharmaceuticals To Report Second Quarter 2015 Financial Results On August 6, 2015

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the quarter ended June 30, 2015, after the close of market on Thursday, August 6, 2015.

Anacor Pharmaceuticals (ANAC) Leading In Pre-Market Activity

Anacor Pharmaceuticals (ANAC) Leading In Pre-Market Activity

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a pre-market leader candidate

Today's Stocks Driving Success For The Drugs Industry

Today's Stocks Driving Success For The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Today Anacor Pharmaceuticals (ANAC) Hits New Lifetime High

Today Anacor Pharmaceuticals (ANAC) Hits New Lifetime High

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a new lifetime high candidate

Anacor Pharmaceuticals (ANAC) Is Weak On High Volume Today

Anacor Pharmaceuticals (ANAC) Is Weak On High Volume Today

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a weak on high relative volume candidate